Cite Filings / DNTH / 0000902219-25-000435

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Dianthus Therapeutics, Inc. /DE/ Filed 2025-11-12 Acc 0000902219-25-000435

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-04-27 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-14 4 EVP, Head of R&D sold 196,538 shares at an average $37.55 ($7,379,887)
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-13 144 Sale of Securities
2025-11-12 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-12 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…